Technical Analysis for EPRSQ - Epirus Biopharm Inc

Grade Last Price % Change Price Change
grade B 0.002 0.00% 0.0000
EPRSQ closed unchanged on Monday, October 21, 2019, on 2.42 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical EPRSQ trend table...

Date Alert Name Type % Chg
Lizard Bearish Bearish Day Trade Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 20 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%

Older signals for EPRSQ ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
EPIRUS Biopharmaceuticals, Inc. (Epirus) is a biopharmaceutical company. The Company focuses on biosimilars, which are biologic drugs. Its segment is the development and commercialization of biosimilar monoclonal antibodies for emerging markets. The Company's products include BOW015, a biosimilar version of Remicade, which is a monoclonal antibody against tumor necrosis factor alpha (TNF-a); BOW050, a biosimilar version of Humira, which is an inhibitor of TNF-a used to treat inflammatory diseases; BOW070, a biosimilar version of Actemra, which is an immunosuppressive drug for the treatment of rheumatoid arthritis, polyarticular arthritis and systemic juvenile idiopathic arthritis; BOW090, a biosimilar version of STELARA, which is an immunosuppressant drug for the treatment of plaque psoriasis and psoriatic arthritis; BOW100, a biosimilar version of SIMPONI, which is an inhibitor of TNF-a, and BOW080, a biosimilar version of Soliris, which is used to treat ultra-rare blood disorders.
Medicine Biotechnology Medical Specialties Biopharmaceutical Drugs Antibodies Alpha Monoclonal Antibodies Rheumatoid Arthritis Inflammatory Diseases Janssen Biotech Plaque Psoriasis Remicade Tnf Inhibitors Biosimilar Immunosuppressants Infliximab
Is EPRSQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.0071
52 Week Low 0.0001
Average Volume 27,871
200-Day Moving Average 0.0014
50-Day Moving Average 0.0016
20-Day Moving Average 0.0018
10-Day Moving Average 0.0017
Average True Range 0.0007
ADX 24.08
+DI 45.679
-DI 24.6914
Chandelier Exit (Long, 3 ATRs ) 0.0015
Chandelier Exit (Short, 3 ATRs ) 0.0022
Upper Bollinger Band 0.0027
Lower Bollinger Band 0.0009
Percent B (%b) 0.61
BandWidth 100.0
MACD Line 0.0001
MACD Signal Line 0.0001
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0023
Resistance 3 (R3) 0.0023 0.0023 0.0023
Resistance 2 (R2) 0.0023 0.0022 0.0023 0.0022
Resistance 1 (R1) 0.0021 0.0021 0.0021 0.0021 0.0022
Pivot Point 0.0021 0.0021 0.0021 0.0021 0.0021
Support 1 (S1) 0.0019 0.0020 0.0019 0.0019 0.0018
Support 2 (S2) 0.0019 0.0019 0.0019 0.0018
Support 3 (S3) 0.0017 0.0019 0.0018
Support 4 (S4) 0.0017